The role of intravenous iron in anemia management and transfusion avoidance

Transfusion

Volumn 48, Issue 5, 2008, Pages 988-1000

  Auerbach, Michael ^a   Goodnough, Lawrence Tim ^a   Picard, Dan ^a   Maniatis, Alice ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FERROUS SULFATE; HEPCIDIN; IRON DEXTRAN; IRON SACCHARATE; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG USE; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY ANEMIA; PROTEIN SYNTHESIS; REVIEW; TREATMENT INDICATION;

ANEMIA, IRON-DEFICIENCY; BLOOD TRANSFUSION; ERYTHROPOIESIS; FERRIC COMPOUNDS; HEMATINICS; HUMANS; INJECTIONS, INTRAVENOUS;

EID: 42949084115     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01633.x     Document Type: Review

References (90)

1. Goodnough LT, Strasburg D, Riddell J, Verbrugge D, Wish J. Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients? Clin Nephrol 1994 41 : 303 7.
2. Eschbach JW. Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI. Semin Nephrol 2000 20 : 320 9.
3. Eschbach JW, Adamson JW. Iron overload in renal failure patients: changes since the introduction of erythropoietin therapy. Kidney Int Suppl 1999 69 : S35 S43.
4. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000 96 : 823 33.
5. Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis 2001 38 : 988 91.
6. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006 21 : 378 82.
7. Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002 34 : 286 90.
8. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995 26 : 41 6.
9. Macdougall IC, Roche A. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. Am J Kidney Dis 2005 46 : 283 9.
10. Critchley J, Dundar Y. Adverse events associated with intravenous iron infusion (low-molecular-weight iron dextran and iron sucrose): a systematic review. Transfus Altern Transfus Med 2007 9 : 8 36.
11. Moniem KA, Bhandari SU. Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations. Transfus Altern Transfus Med 2007 9 : 37 42.
12. Sav T, Tokgoz B, Sipahioglu MH, Deveci M, Sari I, Oymak O, Utas C. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail 2007 29 : 423 6.
13. Finch CA. Erythropoiesis, erythropoietin, and iron. Blood 1982 60 : 1241 6.
14. Crosby WH. The metabolism of hemoglobin and bile pigment in hemolytic disease. Am J Med 1955 18 : 112 22.
15. Hillman RS, Henderson PA. Control of marrow production by the level of iron supply. J Clin Invest 1969 48 : 454 60.
16. Crosby WH. Treatment of haemochromatosis by energetic phlebotomy; one patient's response to the letting of 55 litres of blood in 11 months. Br J Haematol 1958 4 : 82 8.
17. Coleman DH, Stevens AR Jr, Dodge HT, Finch CA. Rate of blood regeneration after blood loss. AMA. Arch Intern Med 1953 92 : 341 9.
18. Finch CA, Huebers H. Perspectives in iron metabolism. N Engl J Med 1982 306 : 1520 8.
19. Goodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994 34 : 66 71.
20. Goodnough LT, Marcus RE. Erythropoiesis in patients stimulated with erythropoietin: the relevance of storage iron. Vox Sang 1998 75 : 128 33.
21. Weisbach V, Skoda P, Rippel R, Lauer G, Glaser A, Zingsem J, Zimmermann R, Eckstein R. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study. Transfusion 1999 39 : 465 72.
22. Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall MS, Lenes BA, Menitove JE, Silberstein LE, Smith KJ, Wallas CH, Abels R, von Tress M. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989 321 : 1163 8.
23. Goodnough LT, Price TH, Rudnick S, Soegiarso RW. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992 32 : 441 5.
24. Biesma DH, Kraaijenhagen RJ, Poortman J, Marx JJ, van de WA. The effect of oral iron supplementation on erythropoiesis in autologous blood donors. Transfusion 1992 32 : 162 5.
25. Kasper SM, Lazansky H, Stark C, Klimek M, Laubinger R, Borner U. Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation. Transfusion 1998 38 : 764 70.
26. Skikne BS, Cook JD. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992 120 : 746 51.
27. Heiss MM, Tarabichi A, Delanoff C, Allgayer H, Jauch KW, Hernandez-Richter T, Mempel W, Beck KG, Schildberg FW, Messmer K. Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study. Surgery 1996 119 : 523 7.
28. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 1993 81 : 956 64.
29. Biesma DH, Beguin Y, Kraaijenhagen RJ, Marx JJ. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. Eur J Clin Invest 1994 24 : 426 32.
30. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987 316 : 73 8.
31. Sadjadi SA. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995 26 : 1000 1.
32. Means RT Jr. Commentary: an anemia of chronic disease, after all? J Invest Med 1999 47 : 203.
33. Tarng DC, Huang TP, Chen TW, Yang WC. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int Suppl 1999 69 : S107 S118.
34. Wingard RL, Parker RA, Ismail N, Hakim RM. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 1995 25 : 433 9.
35. Adamson JW, Eschbach JW. Erythropoietin for end-stage renal disease. N Engl J Med 1998 339 : 625 7.
36. Silverberg DS, Iaina A, Peer G, Kaplan E, Levi BA, Frank N, Steinbruch S, Blum M. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 1996 27 : 234 8.
37. Taylor JE, Peat N, Porter C, Morgan AG. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients. Nephrol Dial Transplant 1996 11 : 1079 83.
38. Gasche C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997 126 : 782 7.
39. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C, Lochs H, Raedler A. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996 334 : 619 23.
40. Weiss G, Houston T, Kastner S, Johrer K, Grunewald K, Brock JH. Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells. Blood 1997 89 : 680 7.
41. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006 47 (5 Suppl 3 S11 45.
42. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005 352 : 1011 23.
43. Kalantar-Zadeh K, Regidor DL, Mcallister CJ, Michael B, Warnock DG. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol 2005 16 : 3070 80.
44. Hamstra RD, Block MH. Erythropoiesis in response to blood loss in man. J Appl Physiol 1969 27 : 503 7.
45. Beutler E. The utilization of saccharated Fe59 oxide in red cell formation. J Lab Clin Med 1958 51 : 415 9.
46. Wood JK, Milner PF, Pathak UN. The metabolism of iron-dextran given as a total-dose infusion to iron deficient Jamaican subjects. Br J Haematol 1968 14 : 119 29.
47. Beamish MR, Davies AG, Eakins JD, Jacobs A, Trevett D. The measurement of reticuloendothelial iron release using iron-dextran. Br J Haematol 1971 21 : 617 22.
48. Auerbach M, Ballard H, Trout JR, Mcilwain M, Ackerman A, Bahrain H, Balan S, Barker L, Rana J. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 2004 22 : 1301 7.
49. Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufman LR. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist 2007 12 : 231 42.
50. Hedenus M, Birgegard G, Nasman P, Ahlberg L, Karlsson T, Lauri B, Lundin J, Larfars G, Osterborg A. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study. Leukemia 2007 21 : 627 32.
51. Pinter T, Mossman T, Suto J, Vansteenkiste J. Effects of intravenous (IV) iron supplementation on responses to every-3-week (Q3W) darbepoetin alfa (DA) by baseline hemoglobin in patients (pts) with chemotherapy-induced anemia (CIA) [abstract]. J Clin Oncol 2007 ASCO Annual Meeting Proceedings 25[18S], 9106. 2007.
52. Kim YT, Kim SW, Yoon BS, Cho HJ, Nahm EJ, Kim SH, Kim JH, Kim JW. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol 2007 105 : 199 204.
53. Macdonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990 81 : 301 5.
54. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989 30 : 835 8.
55. de Silva AD, Tsironi E, Feakins RM, Rampton DS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005 22 : 1097 105.
56. Gasche C, Kulnigg S. Intravenous iron in inflammatory bowel disease. Semin Hematol 2006 43 (4 Suppl 6 S18 22.
57. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006 24 : 1507 23.
58. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998 44 : 45 51.
59. al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, Abbas M. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996 69 : 121 4.
60. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol 2002 186 : 518 22.
61. Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol 2005 106 : 1335 40.
62. Dede A, Uygur D, Yilmaz B, Mungan T, Ugur M. Intravenous iron sucrose complex vs. oral ferrous sulfate for postpartum iron deficiency anemia. Int J Gynaecol Obstet 2005 90 : 238 9.
63. Gravier A, Descargues G, Marpeau L. [How to avoid transfusion in the post-partum period: importance of an intravenous iron supplement]. J Gynecol Obstet Biol Reprod (Paris) 1999 28 : 77 8.
64. Zimmermann R, Breymann C, Huch R, Huch A. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration. Clin Invest 1994 72 (6 Suppl S25 S30.
65. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007 369 : 1502 4.
66. Kanakaraddi VP, Hoskatti CG, Nadig VS, Patil CK, Maiya M. Comparative therapeutic study of T.D.I. and I.M. injections of iron dextran complex in anaemia. J Assoc Physicians India 1973 21 : 849 53.
67. Huch R, Breymann C. Anaemia in pregnancy and the puerperium. 2nd ed. Bremen : UNI-MED Science Verlag 2006.
68. Wali A, Mushtaq A, Nilofer. Comparative study - efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. J Pak Med Assoc 2002 52 : 392 5.
69. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG 2006 113 : 1248 52.
70. Polatti F, Mandelli B. Treatment with intravenous iron of hypochromic anemia in pregnancy [translation]. Bolletino della Societa Medico-Chirurgica di Pavia 1983 97 : 13 6.
71. Chamate E. Treatment of iron deficiency anemia in pregnancy and the immediate puerperium and other ferropenic conditions with saccharate iron administered intravenously in fractionated doses. XIVth International Congress of Hematology 1972 Sao Paulo, Brazil.
72. Breymann C. Iron supplementation during pregnancy. Fetal and Maternal Medicine Reviews 2002 13 (1 1 29.
73. Broche DE, Gay C, Armand-Branger S, Grangeasse L, Terzibachian JJ. [Acute postpartum anaemia. Clinical practice and interest of intravenous iron]. Gynecol Obstet Fertil 2004 32 : 613 9.
74. Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfus Med 2007 17 : 1 15.
75. Bernstein LH, Coles M, Granata A. The Bridgeport Hospital experience with autologous transfusion in orthopedic surgery. Orthopedics 1997 20 : 677 80.
76. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003 43 : 459 69.
77. Querin JJ, Stahl LD. 12 simple sensible steps for successful blood transfusions. Nursing 1990 20 : 68 81.
78. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999 81 : 2 10.
79. Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 2005 125 : 342 7.
80. Garcia-Erce JA, Cuenca J, Munoz M, Izuel M, Martinez AA, Herrera A, Solano VM, Martinez F. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005 88 : 235 43.
81. Garcia-Erce JA, Cuenca J, Martinez F, Cardona R, Perez-Serrano L, Munoz M. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med 2006 16 : 335 41.
82. Munoz M, Naveira E, Seara J, Palmer JH, Cuenca J, Garcia-Erce JA. Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. Transfus Med 2006 16 : 137 42.
83. Madi-Jebara SN, Sleilaty GS, Achouh PE, Yazigi AG, Haddad FA, Hayek GM, Antakly MC, Jebara VA. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004 18 : 59 63.
84. Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007 83 (5 Suppl S27 S86.
85. Braga M, Gianotti L, Vignali A, Gentilini O, Servida P, Di Bordignon CC, V. Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg 1995 82 : 1637 40.
86. Braga M. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 1998 85 : 1306 7.
87. Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, Androulakis G. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 2003 237 : 417 21.
88. Rau B, Schlag PM, Willeke F, Herfarth C, Stephan P, Franke W. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO). Eur J Cancer 1998 34 : 992 8.
89. Kettelhack C, Hones C, Messinger D, Schlag PM. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 1998 85 : 63 7.
90. Munoz M, Campos A, Garcia-Erce JA. Intravenous iron in colorectal surgery. Semin Hematol 2006 43 (4 Suppl 6 S36 8.